Product
Somatuline ATG
1 clinical trial
2 indications
Indication
AcromegalyClinical trial
A Phase 1b Study in Patients With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) to Characterize the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Debio 4126, a 12-week Prolonged-release Octreotide FormulationStatus: Active (not recruiting), Estimated PCD: 2024-11-01